EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,090,000 | +24.3% | 208,598 | +22.8% | 0.10% | -16.1% |
| Q2 2022 | $1,682,000 | +2.1% | 169,858 | +1.4% | 0.12% | -33.3% |
| Q1 2022 | $1,648,000 | +0.8% | 167,525 | 0.0% | 0.18% | -38.3% |
| Q4 2021 | $1,635,000 | -0.2% | 167,525 | 0.0% | 0.29% | +15.7% |
| Q3 2021 | $1,638,000 | -0.6% | 167,525 | +0.1% | 0.25% | +0.8% |
| Q2 2021 | $1,648,000 | – | 167,425 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |